We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Azelastine

News List

FDA Approves Astepro Allergy (azelastine) Nasal Spray for Over-the-Counter Use drugs
June 18, 2021
Bayer announced today that the U.S. Food and Drug Administration (FDA) has approved Astepro Allergy (Azelastine HCI .15%) as an over-the-counter (OTC) product for the temporary relief of nasal congestion, runny nose, sneezing and itchy nose due.
FDA Approves a Nasal Antihistamine for Nonprescription Use fda.gov
June 18, 2021
The U.S. Food and Drug Administration today approved a nasal antihistamine for nonprescription use through a process called a partial prescription to nonprescription switch.
CEBINA Reports Positive Findings on Azelastine Potency for COVID-19 americanpharmaceuticalreview
September 27, 2020
CEBINA GmbH has announced further positive results in its collaborative COVID-19 drug repurposing project, demonstrating allergy nasal spray medication containing azelastine has potent efficacy against SARS-CoV-2 in a human 3D nasal tissue model.
CEBINA Identifies Common Antihistamine Nasal Spray as a Potential Anti-COVID-19 Approach americanpharmaceuticalreview
July 20, 2020
CEBINA GmbH has announced positive results of its COVID-19 drug repurposing project with the identification of commonly used approved drugs with activity against SARS-CoV-2 infection in in vitro assays.